investorscraft@gmail.com

Intrinsic ValueCalnex Solutions plc (CLX.L)

Previous Close£45.50
Intrinsic Value
Upside potential
Previous Close
£45.50

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Calnex Solutions plc operates in the communication equipment sector, specializing in advanced test instrumentation and solutions for network synchronization and emulation. The company serves telecoms networks, enterprise networks, and data centers globally, offering products like Paragon-neo for 5G testing and NE-ONE for performance validation across diverse network environments. Its solutions address critical needs in synchronization, latency, and performance testing, positioning Calnex as a key player in ensuring network reliability and efficiency. The company’s revenue model is driven by hardware and software sales, supported by a network of regional resellers and distributors. Calnex competes in a niche but growing market, with its technology playing a pivotal role in the rollout of 5G and cloud infrastructure. Its focus on high-precision testing and emulation tools differentiates it from broader competitors, catering to specialized demands in telecom and enterprise networks. The company’s strong R&D focus and partnerships with industry leaders underscore its market position as a trusted provider of cutting-edge network testing solutions.

Revenue Profitability And Efficiency

Calnex reported revenue of £16.3 million for FY 2024, with net income of £40,000, reflecting tight margins in a competitive landscape. Diluted EPS stood at 0.04p, indicating minimal profitability. Operating cash flow was negative at £784,000, partly offset by modest capital expenditures of £111,000. The company’s financial performance suggests challenges in scaling profitability despite its specialized market focus.

Earnings Power And Capital Efficiency

The company’s earnings power appears constrained, with net income representing a slim margin of 0.2% of revenue. Capital efficiency metrics are not robust, as evidenced by negative operating cash flow. However, Calnex maintains a strong cash position of £11.9 million, providing liquidity to navigate near-term challenges and invest in growth initiatives.

Balance Sheet And Financial Health

Calnex’s balance sheet is relatively healthy, with cash and equivalents of £11.9 million outweighing total debt of £415,000. The low leverage ratio indicates minimal financial risk, supported by a solid equity base. The company’s financial health is further underscored by its ability to fund operations without significant reliance on external financing.

Growth Trends And Dividend Policy

Growth trends are muted, with revenue and profitability showing limited expansion. The company declared a dividend of 1p per share, signaling a commitment to shareholder returns despite modest earnings. Future growth may hinge on demand for 5G and cloud infrastructure testing, though execution risks remain given the competitive and cyclical nature of the industry.

Valuation And Market Expectations

With a market cap of £48.3 million, Calnex trades at approximately 3x revenue, reflecting modest investor expectations. The beta of 1.69 suggests higher volatility compared to the broader market, likely due to its niche focus and smaller scale. Market sentiment appears cautious, balancing the company’s technological strengths against its profitability challenges.

Strategic Advantages And Outlook

Calnex’s strategic advantages lie in its specialized product portfolio and expertise in network synchronization testing, critical for 5G and cloud adoption. The outlook depends on its ability to capitalize on these trends while improving operational efficiency. Success will require scaling revenue without compromising margins, leveraging its strong cash position to invest in innovation and market expansion.

Sources

Company filings, London Stock Exchange data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount